J. Goldman & Co LP - VIVEVE MED INC ownership

VIVEVE MED INC's ticker is VIVE and the CUSIP is 92852W204. A total of 56 filers reported holding VIVEVE MED INC in Q1 2018. The put-call ratio across all filers is 1.00 and the average weighting 0.2%.

Quarter-by-quarter ownership
J. Goldman & Co LP ownership history of VIVEVE MED INC
ValueSharesWeighting
Q2 2019$116,000
-77.0%
305,556
-43.2%
0.01%
-71.4%
Q1 2019$505,000
+39.5%
537,600
+55.8%
0.03%0.0%
Q4 2018$362,000
+48.4%
345,016
+279.1%
0.03%
+64.7%
Q3 2018$244,000
-59.4%
91,000
-58.8%
0.02%
-45.2%
Q2 2018$601,000
-61.2%
221,000
-47.8%
0.03%
-53.0%
Q1 2018$1,550,000
+1.5%
423,543
+37.9%
0.07%
-17.5%
Q4 2017$1,527,000
+61.9%
307,198
+70.7%
0.08%
+66.7%
Q3 2017$943,000180,0000.05%
Other shareholders
VIVEVE MED INC shareholders Q1 2018
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 3,849,711$10,471,0006.36%
RTW INVESTMENTS, LP 2,861,023$7,782,0000.56%
Nantahala Capital Management 3,948,132$10,739,0000.44%
Granahan Investment Management 792,607$2,156,0000.13%
ACUTA CAPITAL PARTNERS, LLC 267,500$728,0000.13%
KNOTT DAVID M 71,449$194,0000.07%
WEXFORD CAPITAL LP 349,100$950,0000.06%
HighTower Advisors, LLC 1,821,456$4,957,0000.04%
MEITAV INVESTMENT HOUSE LTD 310,000$800,0000.04%
J. Goldman & Co LP 221,000$601,0000.03%
View complete list of VIVEVE MED INC shareholders